Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Salomaa

Showing results (581-590 of 991) with videos related to

Pageof 100
Sort By:
Circulation|December 15, 1996
Decline of coronary heart disease mortality in Finland during 1983 to 1992: roles of incidence, recurrence, and case-fatality. The FINMONICA MI Register StudyV Salomaa, H Miettinen, K Kuulasmaa, et al.
American Journal of Human Genetics|July 11, 2020
A Platelet Function Modulator of Thrombin Activation Is Causally Linked to Cardiovascular Disease and Affects PAR4 Receptor SignalingBenjamin A T Rodriguez, Arunoday Bhan, Andrew Beswick, et al.
Nature Communications|February 3, 2023
Atlas of plasma NMR biomarkers for health and disease in 118,461 individuals from the UK BiobankHeli Julkunen, Anna Cichońska, Mika Tiainen, et al.
European Heart Journal|May 15, 2001
Gender differences in recurrent coronary events; the FINMONICA MI registerP J Schreiner, M Niemelä, H Miettinen, et al.
Journal of Internal Medicine|March 15, 2022
Genetic and observational evidence: No independent role for cholesterol efflux over static high-density lipoprotein concentration measures in coronary heart disease risk assessmentSanna Kuusisto, Minna K Karjalainen, Therese Tillin, et al.
Circulation|May 26, 2010
Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker projectStefan Blankenberg, Tanja Zeller, Olli Saarela, et al.
Clinical Drug Investigation|March 29, 2008
Comparison of a Multidose Powder Inhaler Containing Beclomethasone Dipropionate (BDP) with a BDP Metered Dose Inhaler with Spacer in the Treatment of Asthmatic PatientsA Poukkula, K Alanko, K Kilpiö, et al.
Journal of Internal Medicine|November 21, 2008
Common candidate gene variants are associated with QT interval duration in the general populationA Marjamaa, C Newton-Cheh, K Porthan, et al.
Genetic Epidemiology|November 4, 2008
The impact of newly identified loci on coronary heart disease, stroke and total mortality in the MORGAM prospective cohortsJuha Karvanen, Kaisa Silander, Frank Kee, et al.
Circulation. Cardiovascular Genetics|April 23, 2016
Cardiovascular Risk Factors and Ischemic Heart Disease: Is the Confluence of Risk Factors Greater Than the Parts? A Genetic ApproachRoberto Elosua, Carla Lluís-Ganella, Isaac Subirana, et al.
Pageof 100

Showing results (581-590 of 991) with videos related to

Sort By:
Pageof 100
Circulation|December 15, 1996
Decline of coronary heart disease mortality in Finland during 1983 to 1992: roles of incidence, recurrence, and case-fatality. The FINMONICA MI Register StudyV Salomaa, H Miettinen, K Kuulasmaa, et al.
American Journal of Human Genetics|July 11, 2020
A Platelet Function Modulator of Thrombin Activation Is Causally Linked to Cardiovascular Disease and Affects PAR4 Receptor SignalingBenjamin A T Rodriguez, Arunoday Bhan, Andrew Beswick, et al.
Nature Communications|February 3, 2023
Atlas of plasma NMR biomarkers for health and disease in 118,461 individuals from the UK BiobankHeli Julkunen, Anna Cichońska, Mika Tiainen, et al.
European Heart Journal|May 15, 2001
Gender differences in recurrent coronary events; the FINMONICA MI registerP J Schreiner, M Niemelä, H Miettinen, et al.
Journal of Internal Medicine|March 15, 2022
Genetic and observational evidence: No independent role for cholesterol efflux over static high-density lipoprotein concentration measures in coronary heart disease risk assessmentSanna Kuusisto, Minna K Karjalainen, Therese Tillin, et al.
Circulation|May 26, 2010
Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker projectStefan Blankenberg, Tanja Zeller, Olli Saarela, et al.
Clinical Drug Investigation|March 29, 2008
Comparison of a Multidose Powder Inhaler Containing Beclomethasone Dipropionate (BDP) with a BDP Metered Dose Inhaler with Spacer in the Treatment of Asthmatic PatientsA Poukkula, K Alanko, K Kilpiö, et al.
Journal of Internal Medicine|November 21, 2008
Common candidate gene variants are associated with QT interval duration in the general populationA Marjamaa, C Newton-Cheh, K Porthan, et al.
Genetic Epidemiology|November 4, 2008
The impact of newly identified loci on coronary heart disease, stroke and total mortality in the MORGAM prospective cohortsJuha Karvanen, Kaisa Silander, Frank Kee, et al.
Circulation. Cardiovascular Genetics|April 23, 2016
Cardiovascular Risk Factors and Ischemic Heart Disease: Is the Confluence of Risk Factors Greater Than the Parts? A Genetic ApproachRoberto Elosua, Carla Lluís-Ganella, Isaac Subirana, et al.
Pageof 100